Trial · NCT01387607
Results by group74
Each measurement the trial posted, group by group, in the words and numbers it posted.
61 to 74 of 74
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline at Week 14 in Hospital Anxiety and Depression Scale (HADS) - Depression Subscale Score | Pregabalin | -1.11 | Standard Error 0.290 | Units on a scale | |
| Change From Baseline at Week 14 in Hospital Anxiety and Depression Scale (HADS) - Depression Subscale Score | Placebo | -0.28 | Standard Error 0.294 | Units on a scale | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Discontinuation Due to AEs | Pregabalin | AEs | 119 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Discontinuation Due to AEs | Placebo | AEs | 103 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Discontinuation Due to AEs | Pregabalin | SAEs | 0 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Discontinuation Due to AEs | Placebo | SAEs | 9 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Discontinuation Due to AEs | Pregabalin | Discontinuation due to AEs | 22 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and Discontinuation Due to AEs | Placebo | Discontinuation due to AEs | 11 | Participants | |
| Number of Treatment-Emergent Adverse Events (TEAEs) Categorized by Severity | Pregabalin | Mild AEs | 183 | Events | |
| Number of Treatment-Emergent Adverse Events (TEAEs) Categorized by Severity | Placebo | Mild AEs | 162 | Events | |
| Number of Treatment-Emergent Adverse Events (TEAEs) Categorized by Severity | Pregabalin | Moderate AEs | 52 | Events | |
| Number of Treatment-Emergent Adverse Events (TEAEs) Categorized by Severity | Placebo | Moderate AEs | 30 | Events | |
| Number of Treatment-Emergent Adverse Events (TEAEs) Categorized by Severity | Pregabalin | Severe AEs | 38 | Events | |
| Number of Treatment-Emergent Adverse Events (TEAEs) Categorized by Severity | Placebo | Severe AEs | 25 | Events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01387607/results?page=4